Board of Directors

BerGenBio’s Board of Directors is composed of experienced biopharmaceutical executives with experience of developing next generation cancer drugs and building world class innovative oncology biotechnology companies. The Board also represents leading investors and has substantial commercial experience to navigate the development of the Company.

Mr. Anders Tullgren

Chair

Anders Tullgren joined the board in 2022 and has over…

Read more

Dr. Debra Barker

Non-Executive Director

Debra Barker joined the board in 2019 and is a…

Read more

Dr. Sally Bennett

Non-Executive Director

Dr Sally Bennett joined the board in 2020 and has…

Read more

Mr. David Colpman

Non-Executive Director

David Colpman joined the board in 2024 and has 35+ years…

Read more